METiS Therapeutics revenue hit $3.7M in 2024

METiS Therapeutics generates revenue from customers

METiS Therapeutics

Cambridge, Massachusetts, United States

About Company RevenueTeamFounder/CEOCEO Net Worth

How METiS Therapeutics hit $3.7M revenue with a 38 person team in 2023.

The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics, and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical, and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection, and formulation design. METiS, founded by a team of MIT researchers, serial entrepreneurs, and biotech industry veterans, develops and in-licenses novel assets with high therapeutic potential to leverage its data-driven platform for advancements in the field.

Revenue

$3.7M

2023 Revenue

YOY

-----

YOY

Funding

$86M

Funding

METiS Therapeutics Revenue

In 2023, METiS Therapeutics revenue run rate hit $3.7M in revenue.

  • 2023

    METiS Therapeutics hit $3.7M in revenue in 2023

  • METiS Therapeutics launched in with $0 revenue

METiS Therapeutics Funding History


No funding has been reported for METiS Therapeutics yet.

Team

METiS Therapeutics has 38 total employees.

DISTRIBUTION QTY
Total team size 38

Founder / CEO

Wenshou Wang

Q&A

  • What's your age?

    -

  • Favorite online tool?

    -

  • Favorite book?

    -

  • Favorite CEO?

    -

  • Advice for 20 year old self

    -

Customers

Churn

METiS Therapeutics Executives

Name Position Working Email Personal Email
Wenshou Wang CEO - -

METiS Therapeutics Employees

Name Position Working Email Personal Email
Wenshou Wang CEO - -

Frequently Asked Questions about METiS Therapeutics

  • When was METiS Therapeutics founded?

    METiS Therapeutics was founded in .

  • How much revenue does METiS Therapeutics generate?

    METiS Therapeutics generates $3.7M in revenue.

  • Who is the CEO of METiS Therapeutics

    The CEO of METiS Therapeutics is Wenshou Wang.

  • How much funding does METiS Therapeutics have?

    METiS Therapeutics raised $86M.

  • How many employees does METiS Therapeutics have?

    METiS Therapeutics has 38 employees.

  • Where is METiS Therapeutics headquarters?

    METiS Therapeutics is headquartered at Cambridge, Massachusetts, United States

People Also Viewed

MaestroQA

Provider of an open market orchestration platform intended to track customer behavior and analyze their preferences. The company's platform tracks application usage, feedback, user psychology and analytics of customer experience to deliver personalized and coordinated marketing experiences across marketing channels, enabling managers to empower agents with real-time feedback, granular insight into agent performance and pinpointed coaching.

Clavister

Clavister is a provider of web based security and unified threat management software. The company offers virtual series network security products for virtual and cloud based security that include virtual private server, virtual private cloud and hosted data center. The company continues to grow by making periodic small acquisitions.

eifas

SaaS Financial Advisory Platform

Sensika Technologies

Sensika Technologies, a cloud-based, single-access-point information intelligence platform, supports sound and agile business decisions.

LeaseWorks

LeaseWorks provides cloud based asset management, customer relationship management and other software products that help airlines and lessors save time, reduce costs, optimize revenue and manage risk.

TIMP

Developer of comprehensive management software. The company develops a global management software specialized in appointments and reservations through a mobile app, focusing on wellness and fitness related businesses, helping them to turn into an online service that is available 24/7 while saving time and increasing efficiency.